NCT Number: NCT00293878
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Coastal Clinical Research, Mobile, Alabama, United States
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Mild to moderate primary hypercholesterolemia
- Able to give informed consent and to comply with study procedures (including diet)
Exclusion criteria
- Homozygous familial hypercholesterolemia
- Age <18 or >75 years
- Pregnant women or women of child-bearing potential
Treatment and study plan
Primary outcomes
-
Percent change from baseline in LDL-C at 12 weeks
Secondary outcomes
-
Percent change from baseline in TC, HDL-C, TG, HDL:LDL ratio and CRP at 12 weeks
-
Percent change from baseline in serum lipids at 2, 4 and 8 weeks
-
Safety
Sponsors and collaborators
Lead sponsor
Forbes Medi-Tech
Industry
Registry information
Official study title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Effects on Lipids of 12 Weeks of 2 Doses of FM-VP4 in Subjects With Primary Hypercholesterolemia
Important dates
- Study start
- 2005
- First posted
- Feb 20, 2006
- Registry last updated
- Feb 26, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Alleviation of Hypercholesterolemia Through Newly Developed Cookies Supplementedwithpumpkin (Cucurbita Pepo L.) Seeds and Walnuts (Juglans Regia L.) Among Arthrosclerosispatients.
NCT07737067
Arthrosclerosis, Dyslipidemias
Lahore, Punjab Province, Pakistan
View Trial DetailsA Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)
NCT05694260
Dyslipidemias, Hypercholesterolemia
Los Angeles, California, United States
View Trial DetailsTo Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
NCT07655960
Dyslipidemia, Dyslipidemias
Seoul, South Korea
View Trial DetailsAssessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study
NCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial Details